Code | 8024C | ||||||||||
MA number | 78/0177/18-S | ||||||||||
Product Form: | cps dur 28x40 mg (blis.PA/Al/PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | G.L. Pharma GmbH, Austria | ||||||||||
Therapeutic Class: | 78 - SYMPATHOMIMETICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 25.05.2018 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Atofab 40 mg_cps dur_05/2018_REG.doc |
PIL: | PIL_Atofab_cps dur_07_2022.pdf |
Safety feature | Yes |
Data update: | 23.11.2022 |